Safety and Efficacy of Bexarotene in Relapsing–Remitting MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Bexarotene in Patients With Relapsing-Remitting Multiple Sclerosis (CCMR One): A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2a Study
Lancet Neurol 2021 Sep 01;20(9)709-720, JWL Brown, NG Cunniffe, F Prados, B Kanber, JL Jones, E Needham, Z Georgieva, D Rog, OR Pearson, J Overell, D MacManus, RS Samson, J Stutters, C Ffrench-Constant, CAM Gandini Wheeler-Kingshott, C Moran, PD Flynn, AW Michell, RJM Franklin, S Chandran, DR Altmann, DT Chard, P Connick, AJ ColesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.